Neuronetics, Inc. (NASDAQ:STIM) Q3 2021 Earnings Conference Call November 9, 2021 8:30 AM ET Company Participants Mike Vallie - Westwicke Partners Keith Sullivan - President and Chief Executive Officer Steve Furlong - Chief Financial Officer Conference Call Participants Margaret Kaczor - William Blair & Company Matthew O'Brien - Piper Sandler Bill Plovanic - Canaccord Genuity Operator Good day and thank you fro standing by. Welcome to the Neuronetics' Third Quarter 2021 Financial and Operating Results Co ...

Neuronetics, Inc. (NASDAQ:STIM) Q2 2021 Earnings Conference Call August 3, 2021 8:30 AM ET Company Participants Mark Klausner - Managing Partner Keith Sullivan - President and Chief Executive Officer Steve Furlong - Senior VP, CFO & Treasurer Conference Call Participants Margaret Kaczor - William Blair Adam Maeder - Piper Sandler Bill Plovanic - Canaccord Marie Thibault - BTIG Operator Good day, and thank you for standing by and welcome to the Neuronetics' Second Quarter 2021 Financial and Operating Results ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission File Number: 001-38546 NEURONETICS, INC. (Exact name of registrant as specified in its charter) incorporation o ...

COMPANY PRESENTATION NASDAQ: STIM August 2021 NeuroStal Disclaimers This presentation contains estimates and other statistical data prepared by independent parties and by Neuronetics, Inc. (the "Company") relating to market size and growth and other data about the industry in which the Company operates. These estimates and data involve a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates and data. Certain statements in this presentation and the accompanyi ...

TRANSFORMING NEUROHEALTH COMPANY PRESENTATION NASDAQ: STIM MAY 2021 neurostar.com | --- | --- | |-------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | Disclaimers | | | This presentation contains estimates and other statistical data prepare ...

Neuronetics, Inc (NASDAQ:STIM) Q1 2021 Earnings Conference Call May 4, 2021 8:30 AM ET Company Participants Mark Klausner – Investor Relations Keith Sullivan – President and Chief Executive Officer Steve Furlong – Chief Financial Officer Conference Call Participants Margaret Kaczor – William Blair Marie Thibault – BTIG Bill Plovanic – Canaccord Matthew O'Brien – Piper Sandler Dave Turkaly – JMP Securities Operator Good day and thank you for standing by. Welcome to the Neuronetics Reports first-quarter 2021 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission File Number: 001-38546 NEURONETICS, INC. (Exact name of registrant as specified in its charter) incorporation ...

Neuronetics | --- | --- | |---------------------------------|-------| | | | | | | | | | | | | | | | | | | | Neuronetics, Inc. | | | NASDAQ: STIM | | | Company Presentation March 2021 | | Disclaimers 2 This presentation contains estimates and other statistical data prepared by independent parties and by Neuronetics, Inc. (the "Company") relating to market size and growth and other data about the industry in which the Company operates. These estimates and data involve a number of assumptions and limitations, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ (State or other jurisdiction of incorporation or organization) Delaware 33-1051425 (I.R.S. Employer Identification No.) 3222 Phoenixville Pike, ...

Neuronetics, Inc. (NASDAQ:STIM) Q4 2020 Results Conference Call March 2, 2021 8:30 AM ET Company Participants Mark Klausner - Westwicke Partners, LLC Keith Sullivan - President & Chief Executive Officer Stephen Furlong - Chief Financial Officer Conference Call Participants Margaret Kaczor - William Blair Bill Plovanic - Canaccord Marie Thibault - BTIG Operator Good morning, ladies and gentlemen, and welcome to the Neuronetics reports Fourth Quarter and Full Year 2020 Financial and Operating Results Call. At ...